Spero Therapeutics, Inc.SPRONASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending higher, below historical average.
Left:
||||
Enterprise value to sales ratio
Latest
0.15
↓ 100% below average
Average (9y)
35.62
Historical baseline
Range
High:195.94
Low:-28.75
Volatility
630.8%
High variability
| Period | Value | Change |
|---|---|---|
| 2024 | 0.15 | +128.7% |
| 2023 | 0.06 | +108.4% |
| 2022 | -0.77 | -100.6% |
| 2021 | 126.84 | +231.8% |
| 2020 | 38.23 | +360.9% |
| 2019 | 8.29 | -48.9% |
| 2018 | 16.22 | +156.4% |
| 2017 | -28.75 | -114.7% |
| 2016 | 195.94 | - |
| 2015 | 0.00 | - |